Report for Riou JF

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Cellular effects of a new farnesyltransferase inhibitor, RPR-115135, in a human isogenic colon cancer cell line model system HCT-116 -
Author(s) : Russo P , Ottoboni C , Falugi C , Reinhold W , Riou JF , Parodi S , O'Connor PM
Ref : Annals of the New York Academy of Sciences , 886 :252 , 1999
PubMedID: 10667232

Title : Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38 - Dodds_1998_J.Pharmacol.Exp.Ther_286_578
Author(s) : Dodds HM , Haaz MC , Riou JF , Robert J , Rivory LP
Ref : Journal of Pharmacology & Experimental Therapeutics , 286 :578 , 1998
Abstract : Dodds_1998_J.Pharmacol.Exp.Ther_286_578
ESTHER : Dodds_1998_J.Pharmacol.Exp.Ther_286_578
PubMedSearch : Dodds_1998_J.Pharmacol.Exp.Ther_286_578
PubMedID: 9655905

Title : Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients - Rivory_1996_Cancer.Res_56_3689
Author(s) : Rivory LP , Riou JF , Haaz MC , Sable S , Vuilhorgne M , Commercon A , Pond SM , Robert J
Ref : Cancer Research , 56 :3689 , 1996
Abstract : Rivory_1996_Cancer.Res_56_3689
ESTHER : Rivory_1996_Cancer.Res_56_3689
PubMedSearch : Rivory_1996_Cancer.Res_56_3689
PubMedID: 8706009